Clinical Trials Logo

Clinical Trial Summary

Acute kidney injury (AKI) is a complex disorder with clinical manifestations ranging from mild dysfunction to complete anuric kidney failure. Its leads to sudden and rapid decline in renal excretory function within hours to days,accompanied by accumulation of nitrogenous waste products such creatinine,urea and other clinically un measured products


Clinical Trial Description

Acute kidney injury (AKI) is an under-recognized morbidity of neonates; the incidence remains unclear due to the absence of a unified definition of AKI in this population and because previous studies have varied greatly in screening for AKI with serum creatinine and urine output assessments. Premature infants may be born with less than half of the nephrons compared with term neonates, predisposing them to chronic kidney disease (CKD) early on in life and as they age. AKI can also lead to CKD, and premature infants with AKI may be at very high risk for long-term kidney problems. AKI in neonates is often multifactorial and may result from prenatal, perinatal, or postnatal insults as well as any combination thereof. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03528837
Study type Observational
Source Assiut University
Contact Mustafa Sh Khalf, Professor
Phone +20112110096
Email mostafa.tawfeek1@med.au.edu.eg
Status Not yet recruiting
Phase
Start date June 30, 2018
Completion date August 1, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT02306642 - Follow-up of AKI in Neonates During Childhood Years N/A